Sep 12, 2011 - 11:27 am
Abstract from 17th International European Society of Gynaecological Oncology (ESGO) Meeting, going on right now:
“HE4 As Prognostic Marker In Endometrial Cancer”
The HE4 (human epididymis protein4) has been shown to have the potential to differentiate between benign endometrial disease and endometrial cancer. The data presented will provide evidence that the HE4 serum levels are an independent prognostic markers for endometrial cancer patients.